Rachel Swiss

1.1k citations
17 papers · 845 indexed · h-index 13
Topics
Mitochondrial Function and Pathology (7 papers)Metabolomics and Mass Spectrometry Studies (5 papers)Drug-Induced Hepatotoxicity and Protection (4 papers)

In The Last Decade

Rachel Swiss

17 papers receiving 828 citations

Peers

Rachel Swiss
Comparison fields: 5 of 89
  • Molecular Biology 327
  • Pharmacology 215
  • Epidemiology 133
  • Microbiology 130
  • Oncology 113
Replace Parnpen Viriyavejakul with:
Parnpen Viriyavejakul Thailand
Helena J. Tutill United Kingdom
Lisl K.M. Shoda United States
Brian Carr United States
W M Eling Netherlands
Angela K. Talley United States
Xia Wu China
Haruaki Tomioka Japan
Raymond H. See Canada
Simon A. Cobbold Australia
Rachel Swiss relative to Parnpen Viriyavejakul Thailand Parnpen Viriyavejakul's profile →
Citations per field
00.5×9.3×
Parnpen Viriyavejakul · 1×
Citations per year

Countries citing papers authored by Rachel Swiss

Since Specialization
Citations

This map shows the geographic impact of Rachel Swiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Swiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Swiss more than expected).

Fields of papers citing papers by Rachel Swiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Swiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Swiss. The network helps show where Rachel Swiss may publish in the future.

Co-authorship network of co-authors of Rachel Swiss

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Swiss. A scholar is included among the top collaborators of Rachel Swiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Swiss. Rachel Swiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 7
2 9
3 9
4 19
5 158
6 34
7 11
8 34
9 94
10 26
11 58
12 59
13 224
14 19
15 15
16 41
17 28

About Rachel Swiss

Rachel Swiss is a scholar working on Pharmacology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health, having authored 17 papers that have together received 845 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (7 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). The work is most often cited by research in Pharmacology (215 citations), Microbiology (130 citations) and Endocrinology (75 citations). Rachel Swiss has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Hervé Agaisse, Yvonne Will, Isabelle Derré, Michael D. Aleo, Paul D. Bonin, David M. Potter, Yi Luo, Sashi Nadanaciva, James T. Hynes and Hayley J. Newton. Their work appears in journals such as PLoS ONE, Hepatology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026